Welcome to LookChem.com Sign In|Join Free

CAS

  • or

133604-03-2

ethyl (4S)-5-(((tert-butyldiphenyl)silyl)oxy)-4-methyl-2(E)-pentenoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

133604-03-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 133604-03-2 Structure

  • Basic information

    1. Product Name: ethyl (4S)-5-(((tert-butyldiphenyl)silyl)oxy)-4-methyl-2(E)-pentenoate
    2. Synonyms: ethyl (4S)-5-(((tert-butyldiphenyl)silyl)oxy)-4-methyl-2(E)-pentenoate
    3. CAS NO:133604-03-2
    4. Molecular Formula:
    5. Molecular Weight: 396.602
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 133604-03-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: ethyl (4S)-5-(((tert-butyldiphenyl)silyl)oxy)-4-methyl-2(E)-pentenoate(CAS DataBase Reference)
    10. NIST Chemistry Reference: ethyl (4S)-5-(((tert-butyldiphenyl)silyl)oxy)-4-methyl-2(E)-pentenoate(133604-03-2)
    11. EPA Substance Registry System: ethyl (4S)-5-(((tert-butyldiphenyl)silyl)oxy)-4-methyl-2(E)-pentenoate(133604-03-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 133604-03-2(Hazardous Substances Data)

133604-03-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 133604-03-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,6,0 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 133604-03:
(8*1)+(7*3)+(6*3)+(5*6)+(4*0)+(3*4)+(2*0)+(1*3)=92
92 % 10 = 2
So 133604-03-2 is a valid CAS Registry Number.

133604-03-2Relevant articles and documents

Stereoselective synthesis of the C3-C15 fragment of callyspongiolide

Reddy Ramidi, Gopal,Yadav, Jhillu S.,Mohapatra, Debendra K.

, p. 3579 - 3582 (2018/09/10)

The synthesis of C3-C15 fragment of callyspongiolide, a 14-membered macrolides isolated from the marine sponge Callyspongia sp., which was collected from the Indonesia, is reported. Highlights of the synthesis include construction of E-olefin through Juli

Determination of the Absolute Configuration of β-Chiral Primary Alcohols Using the Competing Enantioselective Conversion Method

Burns, Alexander S.,Wagner, Alexander J.,Fulton, Jennifer L.,Young, Kyle,Zakarian, Armen,Rychnovsky, Scott. D.

supporting information, p. 2953 - 2956 (2017/06/07)

A method for determining the absolute configuration of β-chiral primary alcohols has been developed. Enantioenriched alcohols were acylated in the presence of either enantiomer of the enantioselective acylation catalyst HBTM, and the faster reaction was determined by measuring product conversion using 1H NMR spectroscopic analysis. An empirical mnemonic was developed that correlates the absolute configuration of the alcohol to the faster reacting catalyst. Successful substrates for this method include primary alcohols that bear a "directing group" on the stereogenic center; directing groups include arenes, heteroarenes, enones, and halides.

Formal synthesis of (+)-crocacin C

Pasqua, Adele E.,Ferrari, Frank D.,Crawford, James J.,Marquez, Rodolfo

, p. 2114 - 2116 (2012/07/13)

The formal synthesis of (+)-crocacin C is reported. The approach described takes advantage of a highly regioselective epoxide cuprate addition and a diastereoselective Overman rearrangement. The synthesis is practical and amenable to scale up.

Furan derivatives, method of synthesis and uses thereof

-

Page/Page column 32-33, (2008/12/06)

The present invention relates to furan derivatives of formula (I), their method of synthesis and uses thereof. Concretely, the compounds disclosed have proved to be inhibitors of glycogen synthase kinase 3β, GSK-3 β, which is known to be involved in different disease and conditions, such as Alzheimer's disease or non-insulin dependent diabetes mellitus. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a GSK-3 mediated disease or condition.

Highly Felkin-Anh Selective Hiyama Additions of Chiral Allylic Bromides to Aldehydes. Application to the First Synthesis of Nephromopsinic Acid and Its Enantiomer

Mulzer, Johann,Kattner, Lars,Strecker, Achim R.,Schr?der, Christian,Buschmann, Jürgen,Lehmann, Christian,Luger, Peter

, p. 4218 - 4229 (2007/10/02)

The chromium(II)-mediated addition ("Hiyama reaction") of the chiral allylic bromides 13, 15, 19, 22, 24, and 27 to achiral and chiral aldehydes proceeds with high Felkin-Anh selectivity with respect to the stereocenter at Cγ in the bromide (Table II). By

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133604-03-2